This AMPK/HIF-1α-driven increase in glycolysis supports ECs proliferation and has been shown to slow the progression of atherosclerosis in certain models, highlighting the complex and sometimes paradoxical role of metabolic signaling in disease [32]. Here, PRKAA1 is linked to atherosclerosis.